Summary
This paper presents a microfluidic platform designed to address a critical bottleneck in diagnostic testing: the separation of biomarkers from blood in resource-limited settings. The centrifugal cross-flow filtration device successfully separates serum from whole blood whilst maintaining compatibility with both hydrophilic and hydrophobic biomarkers, achieving performance equivalent to conventional laboratory methods. The technology may enable point-of-care diagnostics in settings where traditional laboratory infrastructure is unavailable.
UK applicability
The findings relate primarily to diagnostic technology development rather than agricultural or nutritional science. Potential application to UK point-of-care testing infrastructure exists, but the work lies outside the core remit of farming systems and soil health research.
Key measures
Serum separation efficiency; retention of amphiphilic biomarkers in serum; compatibility with hydrophilic and hydrophobic biomarkers
Outcomes reported
The study developed and validated a centrifugal microfluidic cross-flow filtration device capable of separating serum from whole blood at the point of need whilst preserving both hydrophilic and hydrophobic (amphiphilic) biomarkers. The device achieved serum separation efficiency comparable to traditional laboratory methods.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.